Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 59
- Registration Number
- NCT05337228
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT05299099
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease
- Conditions
- Erosive Reflux Disease
- Interventions
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 218
- Registration Number
- NCT05267743
- Locations
- ๐ฐ๐ท
Wonkwang University Hospital, Iksan, Muwang-ro 895, Korea, Republic of
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
- Conditions
- Hypertension
- Interventions
- Drug: Telminone 80 mg
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 46
- Registration Number
- NCT05223101
- Locations
- ๐ฐ๐ท
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)
- Conditions
- COVID-19
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT05113849
- Locations
- ๐ฐ๐ท
Chungbuk National University Hospital, Chungju, Korea, Republic of
๐ฐ๐ทJeonbuk National University Hospital, Jeonju, Korea, Republic of
๐ฐ๐ทSeoul National University Hospital, Seoul, Korea, Republic of
A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers
- Conditions
- Hypertension
- Interventions
- Drug: Telmione plus 80/12.5mg
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 46
- Registration Number
- NCT05040880
- Locations
- ๐ฐ๐ท
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
A Study to Investigate the Effect of Food on the Pharmacokinetics of IN-A002 Capsule in Healthy Male Subjects
- Conditions
- Healthy
- Interventions
- Drug: IN-A002(IN-115314) capsule
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT05019755
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Dept. of Clinical Pharmacology, Seoul, Korea, Republic of
Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT05005065
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Jongro Gu, Korea, Republic of
๐ฐ๐ทSeoul National University Hopsital, Seoul, Korea, Republic of
Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs
- Conditions
- Preventive Peptic Ulcer
- Interventions
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 390
- Registration Number
- NCT04840550
- Locations
- ๐ฐ๐ท
Samsung Medical Center, Seoul, Korea, Republic of
๐ฐ๐ทThe catholic univ. of Korea Eunpyeong ST. Mari's hospital, Seoul, Korea, Republic of
Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT04654065
- Locations
- ๐ฐ๐ท
Chonbuk National University Hospital, Jeonju, Korea, Republic of